Intersect Ent Inc Quick Ratio (XENT) starting from the first quarter 2022 to first quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Intersect Ent Inc   (NASDAQ: XENT)

Intersect Ent Inc 's Quick Ratio

XENT's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Intersect Ent Inc 's Cash & cash equivalent grew by 31.87 % in the Q1 2022 sequentially, while Current Liabilities decreased, this led to improvement in Intersect Ent Inc 's Quick Ratio to 1.09, Quick Ratio remained below Intersect Ent Inc average.

Within Medical Equipment & Supplies industry 166 other companies have achieved higher Quick Ratio than Intersect Ent Inc in first quarter 2022. While Quick Ratio total ranking in the first quarter 2022 has deteriorated compared to the prior quarter from 1591 to 2620.

Explain Quick Ratio?
How much Cash & cash equivalents XENT´s has?
What are XENT´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XENT Quick Ratio (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4		 (Sep 30 2021)
Q3		 (Jun 30 2021)
Q2		 (Mar 31 2021)
Q1
Y / Y Current Liabilities Change 6.6 % 29.18 % 156.8 % 221.27 % 145.44 %
Y / Y Cash & cash equivalent Change -28.2 % -56.38 % -38.03 % -57.47 % -19.59 %
Quick Ratio MRQ 1.09 0.67 1.59 1.27 1.62
XENT's Total Ranking # 2620 # 1591 # 2196 # 1231 # 1730
Seq. Current Liabilities Change -18.8 % 12.55 % 11.88 % 4.27 % -1.6 %
Seq. Cash & cash equivalent Change 31.87 % -52.59 % 40.2 % -18.08 % -19.88 %



Quick Ratio first quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 167
Healthcare Sector # 952
Overall Market # 2620


Quick Ratio Statistics
High Average Low
13.38 6.04 0.34
(Jun 30 2015)   (Jun 30 2014)




Financial Statements
Intersect Ent Inc 's Current Liabilities $ 46 Millions Visit XENT's Balance sheet
Intersect Ent Inc 's Cash & cash equivalent $ 51 Millions Visit XENT's Balance sheet
Source of XENT's Sales Visit XENT's Sales by Geography


Cumulative Intersect Ent Inc 's Quick Ratio

XENT's Quick Ratio for the trailling 12 Months

XENT Quick Ratio

 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months		 (Jun 30 2021)
12 Months		 (Mar 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 64.15 % 105.31 % 160.64 % 118.01 % 69.06 %
Y / Y Cash & cash equivalent TTM Growth -46.41 % -44 % -33.17 % -13.98 % 17.74 %
Quick Ratio TTM 1.14 1.26 1.62 2.27 3.49
Total Ranking TTM # 5830 # 1293 # 5258 # 1167 # 5623
Seq. Current Liabilities TTM Growth 1.46 % 7.02 % 20.27 % 25.69 % 26.9 %
Seq. Cash & cash equivalent TTM Growth -8.03 % -16.69 % -14.32 % -18.36 % -3.89 %

Quick ratio ranking by company, industry and sector >> Back to XENT Financial Strength Comparisons >> Go to Compare XENT Quick Ratio to its Competitors

On the trailing twelve months basis Due to decline in Current Liabilities in the Q1 2022 to $46.41 millions, cumulative Quick Ratio decreased to 1.14 below the Intersect Ent Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 254 other companies have achieved higher Quick Ratio than Intersect Ent Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2021 from 1293 to 5830.

Explain Quick Ratio?
How much Cash & cash equivalents XENT´s has?
What are XENT´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 255
Healthcare Sector # 1230
Within the Market # 5830


trailing twelve months Quick Ratio Statistics
High Average Low
10.6 6.12 1.14
(March 31, 2016)   (Mar 31 2022)




Companies with similar Quick Ratio in the quarter ending Mar 31 2022, within Medical Equipment & Supplies Industry Quick RatioMar 31 2022 MRQ Cash & cash equivalentMar 31 2022 MRQ Current Liabilities
Pear Therapeutics Inc   2.96 $ 137.401  Millions$ 46.379  Millions
Cytosorbents Corporation  2.93 $ 43.023  Millions$ 14.672  Millions
Edap Tms Sa  2.91 $ 70.712  Millions$ 24.313  Millions
Pulse Biosciences Inc   2.88 $ 12.676  Millions$ 4.398  Millions
Solana Company  2.87 $ 6.310  Millions$ 2.199  Millions
Vivos Therapeutics Inc   2.83 $ 17.828  Millions$ 6.292  Millions
Dih Holding Us Inc   2.80 $ 0.594  Millions$ 0.212  Millions
Myomo Inc   2.78 $ 12.943  Millions$ 4.653  Millions
Biolase Inc   2.65 $ 21.809  Millions$ 8.223  Millions
Ss Innovations International Inc  2.60 $ 0.347  Millions$ 0.133  Millions
Sharecare Inc   2.58 $ 253.306  Millions$ 98.167  Millions
Delcath Systems Inc   2.48 $ 20.491  Millions$ 8.258  Millions
Paragon 28 inc   2.44 $ 93.647  Millions$ 38.410  Millions
Intelligent Bio Solutions Inc   2.43 $ 10.756  Millions$ 4.432  Millions
Iridex Corp  2.37 $ 20.621  Millions$ 8.693  Millions
Atricure Inc   2.35 $ 111.397  Millions$ 47.375  Millions
Marizyme Inc   2.30 $ 3.173  Millions$ 1.379  Millions
Achari Ventures Holdings Corp I  2.19 $ 0.615  Millions$ 0.280  Millions
Biotricity Inc   2.17 $ 12.473  Millions$ 5.740  Millions
Inspiremd Inc   2.11 $ 7.798  Millions$ 3.691  Millions
Mimedx Group Inc   2.07 $ 75.676  Millions$ 36.591  Millions
Icad Inc  2.06 $ 29.798  Millions$ 14.461  Millions
Orasure Technologies Inc  2.02 $ 112.224  Millions$ 55.587  Millions
Electromed Inc   1.98 $ 9.844  Millions$ 4.966  Millions
Si bone inc   1.93 $ 27.329  Millions$ 14.167  Millions
Venus Concept Inc   1.92 $ 17.911  Millions$ 9.322  Millions
Harpoon Therapeutics Inc   1.92 $ 112.465  Millions$ 58.583  Millions
Penumbra Inc  1.85 $ 240.341  Millions$ 130.099  Millions
Bioplus Acquisition Corp   1.85 $ 0.443  Millions$ 0.240  Millions
Warby Parker Inc   1.79 $ 230.324  Millions$ 128.742  Millions

Date modified: 2026-09-08T15:10:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.